Product Overview

Sildigra 225 mg is a prescription medication that contains 225 mg of Sildenafil Citrate, a well‑studied inhibitor of phosphodiesterase type 5 (PDE5). Produced by Dharam Distributors, each strip includes ten film‑coated tablets that are intended for oral administration. The product is offered in pack sizes of 90, 120, 150, or 300 tablets, allowing patients to select a quantity that matches their treatment plan. Sildigra is classified under the therapeutic area of erectile dysfunction and is marketed as a high‑strength option for men who have not achieved satisfactory results with lower doses of Sildenafil.

What is Sildigra 225 mg (Sildenafil Citrate)

Sildigra 225 mg represents the brand name for a tablet that delivers a 225 mg dose of Sildenafil Citrate, the same active ingredient found in many FDA‑approved erectile dysfunction treatments. The formulation is bioequivalent to other Sildenafil products, meaning it produces comparable concentrations in the bloodstream when taken as directed. Dharam Distributors, a certified pharmaceutical wholesale company, ensures that each batch meets strict quality standards and is shipped with proper documentation.

Uses and Benefits

The primary indication for Sildigra 225 mg is to help adult men who experience difficulty achieving or maintaining an erection sufficient for sexual activity. Clinical data show that Sildenafil Citrate improves erectile function in approximately 70 % of patients when taken according to instructions. Benefits extend beyond the physical response; many users report increased confidence, reduced anxiety, and an overall improvement in relationship satisfaction. The medication’s onset of action typically occurs within 30 to 60 minutes, and its effect can last up to five hours, providing a flexible window for spontaneous sexual activity. Additionally, the availability of multiple pack sizes enables patients to manage costs while maintaining a consistent supply of medication.

How It Works

Sildenafil Citrate exerts its effect by selectively inhibiting the enzyme phosphodiesterase type 5 (PDE5). This inhibition leads to an accumulation of cyclic guanosine monophosphate (cGMP) in the smooth muscle of the corpora cavernosa, causing relaxation of blood vessels and increased blood inflow to the penis during sexual stimulation. The physiological cascade begins with the release of nitric oxide, which activates guanylate cyclase and raises cGMP levels. By preventing the breakdown of cGMP, Sildigra sustains the erection process. This mechanism has been documented in peer‑reviewed literature, including reviews from the National Center for Biotechnology Information (NCBI) and the U.S. Food and Drug Administration’s drug labeling database.

Dosage Guidelines

Sildigra 225 mg is intended for use on an as‑needed basis, with one tablet taken approximately 30 to 60 minutes before anticipated sexual activity. The tablet should be swallowed whole with water; it may be taken with or without food, though a high‑fat meal can delay absorption and reduce peak plasma concentrations. For most men, a lower starting dose of 50 mg or 100 mg is recommended, and the 225 mg strength is reserved for patients who have not achieved the desired effect with lower doses and who have no contraindications. The maximum recommended frequency is once per day. Adjustments should only be made under the supervision of a qualified healthcare professional, who can evaluate efficacy and tolerability.

Side Effects

Most side effects associated with Sildigra 225 mg are mild and transient, including headache, facial flushing, nasal congestion, dizziness, and visual disturbances such as a blue tint or increased sensitivity to light. Less common but clinically important adverse events may involve prolonged erection (priapism), sudden hearing loss, or severe cardiovascular reactions such as chest pain or arrhythmia. If any side effect persists for more than a few days, worsens, or is accompanied by pain, swelling, or difficulty breathing, medical attention should be sought promptly. For a complete list of reported reactions, consult the product’s prescribing information or a pharmacist.

Warnings and Precautions

Patients must disclose all current medications, especially nitrates for angina, alpha‑blockers, or other PDE5 inhibitors, because combining these agents can cause a sudden, unsafe drop in blood pressure. Sildigra is contraindicated in individuals with severe cardiovascular disease, uncontrolled hypertension, recent stroke or myocardial infarction, or retinitis pigmentosa. The medication is not intended for use by women, children, or adolescents under 18 years of age. Patients with moderate to severe hepatic or renal impairment may require dose reduction, and alcohol consumption should be limited to avoid additive hypotensive effects. Proper storage in a dry place away from heat and moisture is essential to preserve potency. For detailed safety information, refer to the official FDA drug label (FDA) or speak with a licensed prescriber.

Frequently Asked Questions

Q1: How long does it take for Sildigra 225 mg to start working?
A: The majority of users notice the onset of action within 30 to 60 minutes after ingestion, though individual response can be influenced by food intake and metabolism.

Q2: Can Sildigra 225 mg be taken with other medications?
A: It should not be used together with nitrates, certain antihypertensive agents, or other erectile dysfunction drugs without medical supervision, as dangerous interactions may occur.

Q3: Is a prescription required to purchase Sildigra 225 mg?
A: Yes, Sildigra is a prescription‑only medication. A licensed healthcare provider must evaluate suitability before it can be dispensed.

Q4: How should the tablets be stored?
A: Store the tablets at room temperature, away from moisture and heat, and keep the strip sealed until ready to use.

Q5: What should I do if I experience a prolonged erection?
A: If an erection lasts longer than four hours, seek immediate medical attention, as prolonged erection (priapism) can cause permanent tissue damage.

For additional authoritative information, you may consult MedlinePlus (MedlinePlus) and the National Institutes of Health (NIH). Always discuss any concerns or questions with a qualified healthcare professional.

Related Products

• Sildenafil Oral Disintegrating Strips
• Siezta 100 Mg (Sildenafil Citrate)
• Orgie 20 Mg (Tadalafil)
• Vega Polo (Sildenafil Citrate)
• Filagra FXT Plus (Sildenafil Citrate/Fluoxetine)
• Sildigra Soft 100 mg (Sildenafil Citrate)
• Filagra DXT Plus (Sildenafil Citrate/Duloxetine)
• Sildigra XL Plus 150 mg (Sildenafil Citrate)
• Filagra Oral Jelly (Sildenafil Citrate)
• Modula 5 mg (Tadalafil)
• Sildigra Gold 200 mg (Sildenafil Citrate)
• Sildigra 120 mg (Sildenafil Citrate)